Akebia Therapeutics
AKBA
AKBA
87 hedge funds and large institutions have $73.5M invested in Akebia Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% more funds holding
Funds holding: 76 → 87 (+11)
2.42% more ownership
Funds ownership: 27% → 29.42% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
87
Holding in Top 10
1
Calls
$1.33M
Puts
$494K
Top Buyers
| 1 | +$4.83M | |
| 2 | +$2.01M | |
| 3 | +$1.75M | |
| 4 |
Morgan Stanley
New York
|
+$1.16M |
| 5 |
BlackRock
New York
|
+$830K |
Top Sellers
| 1 | -$909K | |
| 2 | -$561K | |
| 3 | -$382K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$122K |
| 5 |
JPMorgan Chase & Co
New York
|
-$117K |